Search Results 211-220 of 1685 for ai产品榜官网,可以ai绘画的网站,ai自学教程网,最好用的ai网站,ai语音生成网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. Clinical Trials

    The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation. Participation eligibility.

  2. Joel Streed | Mayo Clinic News Network - Page 91 of 170

    Pain is real and a major issue in America. According to the National Institutes of Health, pain affects more Americans than diabetes, heart disease and cancer[.

  3. A Randomized, Phase III Study Comparing Alectinib with Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Patients - Mayo Clinic

    This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with critozinib ...

  4. Joel Streed | Mayo Clinic News Network - Page 79 of 170

    After years of dealing with mysterious symptoms, Nicole Rickert was diagnosed with Ehlers-Danlos syndrome. Now she's working with her team at Mayo Clinic to get ...

  5. A Study to Assess Feasibility and Benefit of a Patient-reported Outcomes Quality of Life Tool for Hematology and Medical Oncology - Mayo Clinic

    The purpose of this study is to determine the feasibility and benefit of a patient-reported outcomes quality of life tool for hematology and medical oncology.

  6. A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors - Mayo Clinic

    About this study · Cohort A: Colorectal cancer (CRC); · Cohort B: Gastric and gastroesophageal junction (GEJ) cancer; · Cohort C: Triple-negative breast cancer ( ...

  7. Copyright terms for Mayo Clinic authors

    Mayo Clinic grants publisher a perpetual, non-exclusive, royalty-free license to publish such materials as part of the submitted manuscripts in all media. Other ...

  8. A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy Duration - Mayo Clinic

    A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy ...

  9. A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma - Mayo Clinic

    A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide ...

  10. A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma - Mayo Clinic

    About this study. The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + ...